High-throughput screening (HTS) tests many compounds in parallel against a biological assay, using robotics and miniaturization to automate thousands of small experiments. It helps identify hit compounds that significantly inhibit or otherwise affect a target, before more detailed follow-up. Screening commonly begins with one concentration for rapid activity triage; promising compounds can then undergo testing across multiple concentrations. section 1.4.1 section 7.1.1
A practical HTS workflow typically includes:
- Select a large compound library and an assay that measures the target activity of interest. section 1.4.1 section 2.0
- Measure each compound at a relatively high single concentration, flagging compounds with significant inhibition as potential hits. section 7.1.1
- When resources permit, test multiple concentrations and fit a dose-response curve to estimate IC50, the concentration producing half-maximal inhibition. section 7.1.1
- Use the resulting measurements to train machine-learning models that expand experimental evidence into virtual screening. section 2.0
COVID Moonshot screening campaign
The COVID Moonshot campaign synthesized more than 2,000 designs and used HTS assays to measure Mpro inhibition. For 2,062 synthesized compounds, IC50 values came from dose-response experiments spanning 11 concentrations from 100 to 0.0017 μM. A computational workflow represented the molecules with 2,048-bit Morgan fingerprints and marked compounds below 5 μM IC50 as active for additional analysis. section 7.1 section 7.1.1
Table 2.1 Comparing high-throughput screening and virtual screening.
|
High
Throughput Screening
|
Virtual
Screening
|
|
Test 104 to 106 compounds
|
Test 108 to 1012 compounds
(ultra-large libraries)
|
|
Can only
screen compounds that have been synthesized
|
Can screen
compounds that have not yet been synthesized
|
|
Generates
beneficial, real data
|
Limited
data generation
|
|
Expensive
|
Cheap
|
|
Requires an
assay for experimental measurement of interest
|
Requires a
computational model or rule set; ML-based approaches additionally need
sufficient training data
|
|
Screening a
large library takes days to weeks, including assay development and logistics
|
Can screen
millions of compounds in minutes to hours once a model or workflow is in
place
|
Compare HTS with virtual screening across library size, cost, assay requirements, data generation, and turnaround time. section 2.0
